欧康医药：2025年年度业绩快报公告

Group 1 - The company, Europharma, announced that it expects to achieve an operating revenue of 334,250,823.12 yuan in 2025, representing a year-on-year growth of 7.73% [2] - The net profit attributable to shareholders of the listed company is projected to be 11,623,260.91 yuan, which reflects a year-on-year decline of 48.21% [2]